142 related articles for article (PubMed ID: 11067374)
1. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
2. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
[TBL] [Abstract][Full Text] [Related]
3. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
[TBL] [Abstract][Full Text] [Related]
4. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
Reust CE
J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
[No Abstract] [Full Text] [Related]
5. Improving the sensitivity of cervical cytology: what are the issues?
Myers ER
Am J Manag Care; 2000 Jul; 6(7):838-40. PubMed ID: 11067380
[No Abstract] [Full Text] [Related]
6. Cervical cancer screening and the older woman: obstacles and opportunities.
Brooks SE
Cancer Pract; 1996; 4(3):125-9. PubMed ID: 8826140
[TBL] [Abstract][Full Text] [Related]
7. Optimum screening interventions for gynecologic malignancies.
Lea JS; Miller DS
Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer in India--strategy for control.
Prabhakar AK
Indian J Cancer; 1992 Sep; 29(3):104-13. PubMed ID: 1292993
[TBL] [Abstract][Full Text] [Related]
9. Prospects for newer technologies in cervical cancer screening programmes.
Hailey DM; Lea R
J Qual Clin Pract; 1995 Sep; 15(3):139-45. PubMed ID: 8528539
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening.
Yabroff KR; Kerner JF; Mandelblatt JS
Prev Med; 2000 Oct; 31(4):429-39. PubMed ID: 11006069
[TBL] [Abstract][Full Text] [Related]
11. Economic aspects of screening for cervical cancer in New Zealand.
Bethwaite J; Rayner T; Bethwaite P
N Z Med J; 1986 Oct; 99(811):747-51. PubMed ID: 3464889
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of quality assurance in an organized cervical screening program.
Andrae B; Smith P
Acta Obstet Gynecol Scand; 1999 May; 78(5):429-35. PubMed ID: 10326890
[TBL] [Abstract][Full Text] [Related]
13. Economic impact of automated primary screening for cervical cancer.
Smith BL; Lee M; Leader S; Wertlake P
J Reprod Med; 1999 Jun; 44(6):518-28. PubMed ID: 10394546
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
15. Papanicolaou cervical smears for screening in asymptomatic women.
Barnes BA
Prim Care; 1981 Mar; 8(1):131-40. PubMed ID: 6911755
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing.
Brown AD; Garber AM
JAMA; 1999 Jan; 281(4):347-53. PubMed ID: 9929088
[TBL] [Abstract][Full Text] [Related]
17. Increasing women's participation in Pap smear screening in Australia--how can we tell if the national policy is effective?
Shelley J; Street A
Aust Health Rev; 1992; 15(2):190-9. PubMed ID: 10119050
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening in primary care: issues and recommendations.
Mandelblatt J
Prim Care; 1989 Mar; 16(1):133-55. PubMed ID: 2649899
[TBL] [Abstract][Full Text] [Related]
19. The ultimate goal? It depends.
Brown E
Physician Exec; 1996 Oct; 22(10):50-2. PubMed ID: 10162496
[TBL] [Abstract][Full Text] [Related]
20. Screening patterns for cervical cancer: how best to reach the unscreened population.
Brown CL
J Natl Cancer Inst Monogr; 1996; (21):7-11. PubMed ID: 9023823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
